Company
Headquarters: Shanghai, China
Employees: 2,034
CEO: Ms. Huamin Li
HK$8.99 Billion
HKD as of Jan. 1, 2025
US$1.16 Billion
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Angelalign Technology Inc. engages in the research and development, manufacture, and marketing of clear aligners treatment solutions to dental professionals in China and internationally. It offers digitally-assisted case assessment support and treatment planning services to orthodontists and GP dentists; Clear aligners, a removable, transparent, plastic form of dental braces that treat malocclusion; and iOrtho, a cloud-based service platform, which allows dental professionals to perform various tasks in the entire treatment process. The company also provides orthodontics and cosmetic dentistry services, and other dental services through its dental clinics. It markets four lines of clear aligners, including Angelalign, Angelalign Pro, Angelalign Kid, and COMFOS. Angelalign Technology Inc. was founded in 2003 and is based in Shanghai, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | HK$1.84 B |
| EBITDA | HK$198.3 M |
| Gross Profit TTM | HK$1.17 B |
| Profit Margin | 2.54% |
| Operating Margin | -2.98% |
| Quarterly Revenue Growth | 39.80% |
Angelalign Technology, Inc. has the following listings and related stock indices.
Stock: HKEX: 6699 wb_incandescent